10.1016/S2215-0366(18)30269-4 15 DanielsonM
Burnham already uses evidence-based PRP (platelet-rich plasma) and other biologic treatments where clinical evidence supports them
Peptides Module III Peptides Module IV 7:30 am Peptide Overview and Cancer Treatments William Seeds, MD 8:00 am Cancer Nutrition and Labs James LaValle, RPh 9:30 am Break 10:00 am Peptides Target Cell Cycle Andrew Heyman MD 11:00 am Tumor Targeting Peptides Andrew Heyman MD 12:00 pm Lunch 1:30 pm Cell Penetrating Peptides Tumor Targeting Peptides William Seeds, MD 3:30 pm Break 4:00 pm Peptides Target Tumor Suppressor Protein Peptide Target Transcription Factors Nima Alavi 6:00 pm Close of Session 7:30 am Anti-Aging Protocols: Final Assumptions William Seeds, MD 8:30 am Laboratory Initial Evaluation and Follow Up James LaValle, RPh 9:30 am Break 10:00 am Peptides in the future, Breakthroughs in Peptide Understanding James LaValle, RPh 11:00 am Nutrition and Supplement Protocol James LaValle, RPh 12:00 pm Lunch 1:30 pm Type I and Type II Ground Breaking Origin William Seeds, MD 3:30 pm Break 4:00 pm Peptide Treatment for Acute and Chronic Infections Kent Holtorf, MD 6:00 pm Close of Session 7:30 am Nutrients for Type 2 Diabetes James LaValle, RPh 9:30 am Break 10:00 am Peptides in Treatment of Chronic Fatigue Syndrome William Seeds, MD 12:00 pm Lunch - Sponsored by Legally Mine 1:30 pm Rheumatoid Arthritis, SLE, Psoriasis and PA, Ankylosing Spondylitis William Seeds, MD 3:30 pm Break 4:00 pm Nutrition and Supplements for RA, SLE, PA, AS James LaValle, RPh 5:00 pm Case Studies: Infections and Metabolic Disease William Seeds, MD James LaValle, RPh Kent Holtorf, MD Andrew Heyman, MD Kathy O'Neil-Smith, MD 6:00 pm Close of Session 7:30 am Inflammatory Bowel Disease, Chrons Disease, Ulcerative Colitis Kathy O'Neil-Smith, MD, FAARM 8:30 am Nutrition and Supplements for GI Tract James LaValle, RPh 9:30 am Break 10:00 am Neuroinflammation Andrew Heyman, MD 11:00 am Dementia & Autism William Seeds, MD 12:00 pm Lunch 1:30 pm Amyotrophic Lateral Sclerosis, Multiple Sclerosis Kathy O'Neil-Smith, MD 2:30 pm Alzheimers, Parkinson Kathy O'Neil-Smith, MD 3:30 pm Break 4:00 pm Nutrition and Supplements: Neuronal Disease James LaValle, RPh 5:00 pm Case Studies: Peptides and Neuronal Disease Kathy O'Neil-Smith, MD, FAARM William Seeds, MD James LaValle, RPh Andrew Heyman, MD 6:00 pm Close of Session 3355 Las Vegas Blvd
1 Remove Dihexa vial from refrigeration and allow to reach room temperature (1520 minutes) 2 Clean vial top with alcohol swab and allow to air dry completely 3 Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water) 4 Inject BAC water slowly down the side of the vial do not aim directly at the powder 5 Gently swirl in circular motions DO NOT shake vigorously as this degrades the peptide 6 Allow 23 minutes for full dissolution solution should be clear and colorless 7 Draw calculated dose into an insulin syringe for subcutaneous injection 8 Inject into abdomen, thigh, or upper arm
a-MSH influences a wide variety of body functions, including helping to modulate immune responses and reduce inflammation
